Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae worldwide. The company's products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant to enhance skin, and to support eye, joint and immune health, as well as used as a human dietary supplement and dietary ingredient; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement, which is used for extra energy, strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. It also provides contract extraction services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health foods, nutraceuticals, and dietary supplement markets. The company was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.
Stock data | 2023 | Change |
---|---|---|
Price | $0.79 | N/A |
Market Cap | $4.93M | N/A |
Shares Outstanding | 6.24M | 1.41% |
Employees | 86.00 | N/A |
Shareholder Equity | 16.35M | -16.11% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | -1.44 | N/A |
P/S Ratio | 0.21 | N/A |
P/B Ratio | 0.30 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | -0.2104 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $23.18M | N/A |
Earnings | -$3.44M | N/A |
EPS | -0.55 | N/A |
Earnings Yield | -0.6962 | N/A |
Gross Margin | 0.3132 | N/A |
Operating Margin | -0.126 | N/A |
Net income margin | -0.1484 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $29.73M | N/A |
Total Debt | $11.17M | N/A |
Cash on Hand | $974.00K | N/A |
Debt to Equity | 0.8186 | 27.02% |
Cash to Debt | 0.0872 | -71.01% |
Current Ratio | $1.67 | -50.63% |